VanEck says policy clarity could make Q1 a 'risk-on' quarter
VanEck expects stronger risk appetite in Q1 on improved fiscal and monetary visibility, while warning that Bitcoin's cycle signals remain mixed.
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
Coinbase, Robinhood and Circle are expanding into stablecoins, payments and prediction markets, but their latest earnings show how hard it is to escape cry...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
VanEck expects stronger risk appetite in Q1 on improved fiscal and monetary visibility, while warning that Bitcoin's cycle signals remain mixed.
Bitcoin price today: down to $91.8k as sentiment dithers ahead of CPI test
"I think my withdrawals from my 401(k) and IRA may need to be larger than my current take-home pay."
The Strait of Hormuz, a critical chokepoint for global oil markets, is back in focus for oil traders
Oklo's Meta contract raises nearly as many questions as it answers.
KeyBanc cautious on security budgets in 2026, downgrades CrowdStrike
Britain's JD Sports launches AI shopping for US customers
GeneDx stock falls after 2026 guidance disappoints investors
Bitcoin whales sold $286 million of BTC in January, but a slowdown in the distribution and accelerating bullish momentum could send BTC to $100,000 before...
From fully staked ETFs to customizable institutional vaults, staking is evolving from a secondary consideration into a foundational pillar of EthereumâEUR(...
A new year has unleashed a new round of debate on how much more money America's super-rich should be paying in taxes.
Bernstein upgrades Vertex ahead of key renal trial readouts